Encrylin

Name: Encrylin

Description: medication used to treat type 2 diabetes in conjunction with exercise and diet. It is generally less preferred than metformin and sulfonylureas as an initial treatment.

Generic: Linagliptin

Therapeutic class: dipeptidyl peptidase-4 (DPP-4) inhibitors

Mechanism of Action: Linagliptin is an inhibitor of DPP-4, an enzyme that degrades the incretion hormones glucagon-like peptide-1 (GLP-1) and glucose-dependent insulin tropic polypeptide (GIP).

Drug class: Cardiometabolic